Bezafibrate modifies lipoprotein composition differently in patients with hypercholesterolemia and in patients with combined hyperlipidemia (1990)
- Authors:
- USP affiliated authors: BERNIK, MARCIA MARTINS SILVEIRA - HU ; QUINTAO, EDER CARLOS ROCHA - FM
- Unidades: HU; FM
- Assunto: ENDOCRINOLOGIA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Anais
- Conference titles: Congresso Panamericano de Endocrinologia
-
ABNT
NAKANDAKARE, E et al. Bezafibrate modifies lipoprotein composition differently in patients with hypercholesterolemia and in patients with combined hyperlipidemia. 1990, Anais.. Recife: Hospital Universitário, Universidade de São Paulo, 1990. . Acesso em: 19 abr. 2024. -
APA
Nakandakare, E., Garcia, R. C., Kawakami, R. R., Bernik, M. M. S., Neves, M. Q. T. S., & Quintão, E. C. da R. (1990). Bezafibrate modifies lipoprotein composition differently in patients with hypercholesterolemia and in patients with combined hyperlipidemia. In Anais. Recife: Hospital Universitário, Universidade de São Paulo. -
NLM
Nakandakare E, Garcia RC, Kawakami RR, Bernik MMS, Neves MQTS, Quintão EC da R. Bezafibrate modifies lipoprotein composition differently in patients with hypercholesterolemia and in patients with combined hyperlipidemia. Anais. 1990 ;[citado 2024 abr. 19 ] -
Vancouver
Nakandakare E, Garcia RC, Kawakami RR, Bernik MMS, Neves MQTS, Quintão EC da R. Bezafibrate modifies lipoprotein composition differently in patients with hypercholesterolemia and in patients with combined hyperlipidemia. Anais. 1990 ;[citado 2024 abr. 19 ] - Reduction of lipid and CETP plasma concentrations by dietary plant sterol ester treatment in moderate hypercholesterolemia does not relate to the TAQ1B CETP polymorphism
- Long term treatment of hypercholesterolemia with simvastatin
- Ldl-apheresis in the treatment of one patient with homozygous familial hypercholesterolemia
- Fitoesterol esterificado na dieta diminui a concentração plasmática de colesterol e de CETP relacionada ao polimorfismo 1405V da CETP
- Plasma cholesterol and CETP concentrations are lowered by dietary phytosterol ester but only the cholesterol variation related to the CETP 1405V polymorphism
- Artificial chylomicrons metabolism as a probe for the plasma lipid lowering drug action mechanism
- Disturbances of lipid metabolism in hypothyroidism studied by artificial chylomicrons
- Reduction of lipid and CETP plasma concentrations by dietary plant sterol ester treatment in moderate hypercholesterolemia does not relate to the TAQ1B CETP polymorphism
- Eficiencia dos esteres de fitoesterois alimentares na reducao dos lipides plasmaticos em hipercolesterolemicos moderados
- Metabolismo de emulsoes ricas em triglycerides em pacientes hipertensos tratados com dihidroclorotiazida ou propranolol
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
